Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents.
Caggiano R, Prokhorova E, Duma L, Schützenhofer K, Lauro R, Catara G, Melillo RM, Celetti A, Smith R, Weroha SJ, Kaufmann SH, Ahel I, Palazzo L.
Caggiano R, et al. Among authors: palazzo l.
Neoplasia. 2025 Jan;59:101092. doi: 10.1016/j.neo.2024.101092. Epub 2024 Nov 29.
Neoplasia. 2025.
PMID: 39615107
Free PMC article.